Cargando…

Diagnostic and Prognostic Markers in Liver Cirrhosis

Detalles Bibliográficos
Autores principales:	Augustin, Salvador, Genescà, Joan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826585/ https://www.ncbi.nlm.nih.gov/pubmed/22045396 http://dx.doi.org/10.3233/DMA-2011-0833

Ejemplares similares

Prognostic Assessment and Management of Liver Cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2017)

Sarcopenia as a prognostic indicator of liver cirrhosis
por: Kim, Sung‐Eun, et al.
Publicado: (2021)

Prognostic implications of trunk muscle mass in liver cirrhosis
por: Han, Jimin, et al.
Publicado: (2018)

Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem
por: Vidal-González, Judit, et al.
Publicado: (2020)

Prognostic Evaluation of Patients with Acute Variceal Bleeding
por: Augustin, Salvador, et al.
Publicado: (2011)

The Impact of Sarcopenia and Its Rate of Change on Prognostic Value of Liver Cirrhosis
por: Kang, Seong Hee, et al.
Publicado: (2018)

Diagnostic and Prognostic Markers in Bladder Cancer
por: Ku, Ja Hyeon, et al.
Publicado: (2016)

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
por: Oh, Sooyeon, et al.
Publicado: (2020)

Non-Invasive Diagnostic and Prognostic Evaluation of Liver Cirrhosis and Portal Hypertension
por: Berzigotti, Annalisa, et al.
Publicado: (2011)

Diagnostic and prognostic significance of cell death markers in patients with cirrhosis and acute decompensation
por: Stoffers, Philipp, et al.
Publicado: (2022)

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals
por: Pons, Mònica, et al.
Publicado: (2017)

Diagnostic and Prognostic Role of Serum Interleukin-6 in Malignant Transformation of Liver Cirrhosis
por: Yakut, Mustafa, et al.
Publicado: (2018)

Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis
por: Rivera‐Esteban, Jesús, et al.
Publicado: (2021)

Comment on “Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis”
por: Weng, Fangbin
Publicado: (2021)

Regression of liver cirrhosis: Orthodoxy or paradigm shift?
por: Yu, Su Jong
Publicado: (2015)

Critical issues in the diagnosis and treatment of liver cirrhosis
por: Wang, Xing, et al.
Publicado: (2019)

Liver cirrhosis and sarcopenia: a dreadful combination
por: Kuchay, Mohammad Shafi, et al.
Publicado: (2022)

Bacterial translocation markers in liver cirrhosis
por: Alexopoulou, Alexandra, et al.
Publicado: (2017)

HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis
por: Huang, Yi, et al.
Publicado: (2023)

NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017)

Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis
por: Mancuso, Andrea
Publicado: (2020)

Markers of cardiac injury in patients with liver cirrhosis
por: Šimić, Stjepan, et al.
Publicado: (2023)

Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis
por: Jeong, Soung Won
Publicado: (2017)

Nutrition in Liver Cirrhosis and Transplantation—Current State and Knowledge Gaps
por: Raman, Maitreyi, et al.
Publicado: (2020)

Direct Hyperbilirubinemia as a Predictor of Mortality in Patients with Liver Cirrhosis
por: Lee, Chang Hun, et al.
Publicado: (2021)

Management of decompensated liver cirrhosis in the surgical intensive care unit
por: Kasper, Philipp, et al.
Publicado: (2023)

Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study
por: Allegretti, Andrew S., et al.
Publicado: (2021)

Liver biopsy interpretation & the regression of hepatitis B virus related cirrhosis
por: Grizzi, Fabio, et al.
Publicado: (2014)

Radiocontrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease
por: Jo, Sang-Kyung
Publicado: (2012)

Management of chronic liver diseases and cirrhosis: current status and future directions
por: Xu, Jing-Hang, et al.
Publicado: (2020)

A need for patient-centered care in managing patients with liver cirrhosis
por: Yoon, Eileen L.
Publicado: (2021)

Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis
por: Ebhohon, Ebehiwele, et al.
Publicado: (2021)

Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH
por: Bravo, Miren, et al.
Publicado: (2019)

Factor analysis of the biochemical markers related to liver cirrhosis
por: Kim, Hyun-Jin, et al.
Publicado: (2015)

Liver cirrhosis in children – the role of imaging in the diagnostic pathway
por: Herrmann, Jochen, et al.
Publicado: (2022)

Global burden of cirrhosis and liver cancer due to alcohol: the past, present, and the future
por: Xie, Chencheng, et al.
Publicado: (2023)

Ampullary carcinoma prognostic markers
por: Perkins, Geraldine, et al.
Publicado: (2019)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

Human albumin infusion strategy in liver cirrhosis: liberal or restrictive?
por: Bai, Zhaohui, et al.
Publicado: (2021)

Behavior of Oxidative Stress Markers in Alcoholic Liver Cirrhosis Patients
por: Galicia-Moreno, Marina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_77c2vhlh160i2knu1f902pid2r